Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guidelines: a European Renal Best Practice (ERBP) commentary statement

Tracking of Serum 25-Hydroxyvitamin D Levels During 14 Years in a Population-based Study and During 12 Months in an Intervention Study

(2010) R. Jorde et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Canadian Society of Nephrology Commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD–Mineral and Bone Disorder (CKD-MBD)

(2010) Braden J. Manns et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

KDOQI US Commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD–Mineral and Bone Disorder (CKD-MBD)

(2010) Katrin Uhlig et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Bisphosphonate Use in Chronic Kidney Disease: Association with Adynamic Bone Disease in a Bone Histology Series

(2010) Richard Amerling et al.   BLOOD PURIFICATION

Phosphate Elimination in Modalities of Hemodialysis and Peritoneal Dialysis

(2010) Martin K. Kuhlmann   BLOOD PURIFICATION

Interpretation of serum parathyroid hormone concentrations in dialysis patients: what do the KDIGO guidelines change for the clinical laboratory?

(2010) Jean-Claude Souberbielle et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Cholecalciferol Supplementation in Hemodialysis Patients: Effects on Mineral Metabolism, Inflammation, and Cardiac Dimension Parameters

(2010) P. J. Matias et al.   Clinical Journal of the American Society of Nephrology

Meta-analysis: Serum vitamin D and breast cancer risk

(2010) Lu Yin et al.   EUROPEAN JOURNAL OF CANCER

Use of vitamin D in chronic kidney disease patients

(2010) Anca Gal-Moscovici et al.   KIDNEY INTERNATIONAL

The Effects of Vitamin D Therapy on Left Ventricular Structure and Function – Are These the Underlying Explanations for Improved CKD Patient Survival?

(2010) Adrian Covic et al.   NEPHRON CLINICAL PRACTICE

Awareness of Vascular Calcification Alters Mineral Metabolism Management

(2010) Gérard M. London   SEMINARS IN DIALYSIS

The Case Against Routine Screening for Vascular Calcification in Chronic Kidney Disease

(2010) David Goldsmith   SEMINARS IN DIALYSIS

Effect of Pamidronate on Bone Loss After Kidney Transplantation: A Randomized Trial

(2009) Stephen B. Walsh et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Phosphate Removal With Several Thrice-Weekly Dialysis Methods in Overweight Hemodialysis Patients

(2009) Marcello Tonelli et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Relationship between Bone Histology and Markers of Bone and Mineral Metabolism in African-American Hemodialysis Patients

(2009) C. Moore et al.   Clinical Journal of the American Society of Nephrology

Hypoparathyroidism associated with severe mineral bone disease postrenal transplantation, treated successfully with recombinant PTH

(2009) Ashutosh MAHAJAN et al.   Hemodialysis International

A randomized double-blind pilot study of serum phosphorus normalization in chronic kidney disease: A new paradigm for clinical outcomes studies in nephrology

(2009) Geoffrey A. BLOCK et al.   Hemodialysis International

Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) hepatitis C guidelines: a European Renal Best Practice (ERBP) position statement

(2009) A. Covic et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

High-flux or low-flux dialysis: a position statement following publication of the Membrane Permeability Outcome study

(2009) J. Tattersall et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

UK Renal Registry 11th Annual Report (December 2008): Chapter 10 Biochemistry profile of patients receiving dialysis in the UK in 2007: national and centre-specific analyses

(2009) Alex Hodsman et al.   NEPHRON CLINICAL PRACTICE

Femoral bone mineral density reflects histologically determined cortical bone volume in hemodialysis patients

(2009) T. Adragao et al.   OSTEOPOROSIS INTERNATIONAL

Mortality Risk for Dialysis Patients With Different Levels of Serum Calcium, Phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS)

(2008) Francesca Tentori et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Treatment of Secondary Hyperparathyroidism in CKD Patients with Cinacalcet and/or Vitamin D Derivatives

(2008) T. B. Drueke et al.   Clinical Journal of the American Society of Nephrology

Effects of Sevelamer Hydrochloride and Calcium Carbonate on Renal Osteodystrophy in Hemodialysis Patients

(2008) A. Ferreira et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Bisphosphonate nephrotoxicity

(2008) Mark A. Perazella et al.   KIDNEY INTERNATIONAL

Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease

(2008) A. Covic et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

European best practice quo vadis? From European best practice guidelines (EBPG) to European renal best practice (ERBP)

(2008) C. Zoccali et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Anaemia management in patients with chronic kidney disease: a position statement by the Anaemia Working Group of European Renal Best Practice (ERBP)

(2008) F. Locatelli et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION